Submitted by Anonymous (not verified) on 30 August 2023 - 13:39
Human medicines European public assessment report (EPAR): Reyataz, atazanavir sulfate, HIV Infections, Date of authorisation: 01/03/2004, Revision: 54, Status: Authorised
Source: